Health & Saf. Code, § 127695 · Chapter 10. California Affordable Drug Manufacturing Act of 2020
Health & Saf. Code, § 127695
Text — As published in the Legislative Counsel's database, tables dated October 18, 2026 (pubinfo_2025.zip)
(a) On or before December 31, 2022, CHHSA shall report to the Legislature on both of the following:
(1) A description of the status of all drugs targeted under this chapter.
(2) An analysis of how the activities of CHHSA may impact competition, access to targeted drugs, the costs of those drugs, and the costs of generic prescription drugs to public and private purchasers.
(b) This section shall remain in effect only until January 1, 2028, and as of that date is repealed.
Notes and commentary — not statutory text
History
Amended by Stats. 2022, Ch. 47, Sec. 23. (SB 184) Effective June 30, 2022. Repealed as of January 1, 2028, by its own provisions.
Source of truth
- Edition
- As published in the Legislative Counsel's database, tables dated October 18, 2026 (pubinfo_2025.zip)
- Official file
- https://leginfo.legislature.ca.gov/faces/codes_displaySection.xhtml?lawCode=HSC§ionNum=127695.
- Text hash
- sha256 875b20450851fb9b0ba7e6c0b2426cf8e2fe7e4a0e25a9124a9d7c6320dbffe5
- Composed by
- compose_ca.py 2026-10-22: the Legislative Counsel's CAML content files read by a tokenizer (caml_readers.reader_a); an independent xml.etree reading (caml_readers.reader_b) agrees on every section
Procedural information only. Not legal advice and not a substitute for the advice of an attorney. Confirm the current text with the official publisher before relying on it.